Related Experiment Videos
Topical tissue factor pathway inhibitor improves free-flap survival in a model simulating free-flap errors
M R Ozbeck1, D M Brown, E G Deune
1Division of Plastic Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Journal of Reconstructive Microsurgery
|May 1, 1995
Summary
Topical tissue factor pathway inhibitor (TFPI) significantly improved free flap survival in a rabbit model by preventing microvascular arterial thrombosis. TFPI demonstrated superior efficacy compared to heparin in preventing surgical complications.
Area of Science:
- Vascular Surgery
- Thrombosis Research
- Biomedical Engineering
Background:
- Free flap surgery is susceptible to microvascular complications.
- Vascular pedicle issues like tension and twisting can lead to thrombosis.
- Current preventative measures have limitations.
Purpose of the Study:
- To evaluate topical tissue factor pathway inhibitor (TFPI) efficacy.
- To assess TFPI's ability to prevent microvascular thrombosis in a simulated free flap model.
- To compare TFPI with heparin and control buffer.
Main Methods:
- A rabbit ear model was used, isolating central artery and vein.
- Arterial anastomosis was performed with induced twisting and compression.
- Topical TFPI (1-40 µg/ml), heparin (50 U/ml), or control buffer was applied.
Main Results:
- Control buffer resulted in 20% survival; heparin improved it to 60%.
- TFPI at 4, 10, and 40 µg/ml yielded 89%, 100%, and 97% survival, respectively.
- TFPI demonstrated significantly higher efficacy than heparin (p < 0.05).
Conclusions:
- Topical TFPI effectively prevents microvascular arterial thrombosis.
- TFPI is a promising irrigation solution for free flap surgery.
- TFPI offers superior protection against thrombosis compared to heparin.